ENA 2020 — 32nd EORTC-NCI-AACR Symposium Molecular Targets and Cancer Therapeutics

ENA 2020 is the drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.

Attracting academics, scientists and pharmaceutical industry representatives from across the globe to discuss the latest innovations in drug development, target selection and the impact of new discoveries in molecular biology.

Topics: Cancer research, clinical research, molecular biology, targeted therapies